Table 3.
Ratio of Mean %ID/g in Treated vs Control Groups (Treated:Control Ratio) | ||||
---|---|---|---|---|
[18F]WC-II-89 | [99mTc]Mebrofenin | |||
30 min | 60 min | 30 min | 60 min | |
Blood | 1.8† | 2.9*‡ | 1.5* | 1.5 |
Bone | 1.3 | 1.3† | 1.7* | 1.3 |
Fat | 1.1† | 2.1† | 1.2 | 1.3 |
Heart | 1.6* | 2.1* | 1.3* | 1.1 |
Kidney | 2.2† | 4.8* | 1.5 | 1.7† |
Liver | 3.4* | 2.3* | 7.6† | 2.0 |
Lung | 1.8* | 2.2* | 1.6 | 1.7† |
Muscle | 1.6* | 0.6 | 2.1 | 0.2 |
Spleen | 1.8* | 1.9* | 1.5 | 1.7 |
Thymus | 1.3 | 1.8† | 0.8 | 1.2 |
N=4 in all groups.
%ID/g = Percent injected dose per gram of tissue
p<0.05 when comparing the mean %ID/g of the treated vs untreated control groups for each tracer
p<0.10 when comparing the mean %ID/g of the treated vs untreated control groups for each tracer
Analysis for blood excludes one data point in the control group deemed contaminated (17 %ID/g vs 1.4±0.15 %ID/G for remaining 3 values in the control group for blood; %ID/g for blood from untreated controls in prior experiments was 0.8±0.1, N=4, Table 2). The treated:control ratio for the control blood including the high outlier was 0.77. The p-value was not significant if this outlier was included in the analysis.